The molecular signature of the peripheral cannabinoid receptor 1 antagonist AM6545 in adipose, liver and muscle tissue.

Autor: Dalle S; Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Belgium. Electronic address: sebastiaan.dalle@kuleuven.be., Schouten M; Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Belgium., Deboutte J; Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Belgium., de Lange E; Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Belgium., Ramaekers M; Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Belgium., Koppo K; Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Belgium. Electronic address: katrien.koppo@kuleuven.be.
Jazyk: angličtina
Zdroj: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Oct; Vol. 491, pp. 117081. Date of Electronic Publication: 2024 Aug 30.
DOI: 10.1016/j.taap.2024.117081
Abstrakt: The endocannabinoid system plays an important role in the regulation of metabolism, growth and regeneration of peripheral tissues, including liver, adipose and muscle tissue. Studies in cells, rodents and humans showed that cannabinoid receptor 1 (CB 1 ) antagonist treatment is an effective strategy to improve features of metabolic health such as substrate metabolism, at least in models of metabolic dysregulation. However, acute signaling events that might induce these metabolic adaptations are not understood. It is not clear whether, and to which extent, a single treatment with a CB 1 antagonist induces acute effects in peripheral, metabolic tissues. Therefore, the present study compared the phosphorylation status of signaling pathways and metabolic markers in liver, adipose and muscle tissue of mice treated with the peripherally restricted CB 1 antagonist AM6545 and vehicle-treated mice. Protein kinase A phosphorylation was downregulated in white and brown adipose tissue, whereas the mitogen-activated protein kinase, phospho-extracellular signal-regulated kinase, was higher in liver, white adipose and muscle tissue of AM6545-treated mice. Additionally, Akt-mammalian target of rapamycin activation was higher in all tissues of AM6545-treated mice, whereas the phosphorylation status of metabolic markers remained unaffected. These data indicate that acute CB 1 antagonism is effective to induce phosphorylation events of signaling cascades and metabolic markers in metabolic tissues of healthy, lean mice within a 90-min time window. The observed adaptations to AM6545 treatment do not fully align with earlier in vitro and in vivo findings, which could be ascribed to differences in cell type, exposure intensity (dose and time), health status and species.
Competing Interests: Declaration of competing interest None.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: